August 12, 2020

vwkly-Education

Aim for Excellence

Prescribers Should Restrict the Use of Non-FDA-Approved Compounded Bioidentical Hormones, Except for Specific Medical Circumstances

The use of compounded bioidentical hormone therapies (cBHTs) — an significantly common method to reduce...

The use of compounded bioidentical hormone therapies (cBHTs) — an significantly common method to reduce symptoms of menopause and male hypogonadism — need to be limited to the small amount of individuals who simply cannot reward from an Food and drug administration-approved hormone treatment solution, claims a new report from the Countrywide Academies of Sciences, Engineering, and Drugs.